Morphosys makes equity-linked debut with €325m convert
Morphosys, the German biotech company, has tapped the equity-linked market with a new €325m convertible bond, adding to the flood of issuance from the sector during the pandemic.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: